Table 5.

Sensitivities for individual and combined tumor marker assays in stage I endometrial cancer.

Marker Combination	Controls vs. Endometrial Cancers – Stage I Average Sensitivity at Set Specificity of:
	90%	95%	98%
CA125	30.0%	20.8%	12.9%
HE4	48.4%	37.9%	29.3%
CA72.4	7.6%	5.8%	3.8%
SMRP	14.4%	8.7%	4.4%
CA125 + HE4	51.6%	41.7%	34.4%
CA125 + CA72.4	29.9%	20.6%	13.6%
CA125 + SMRP	28.8%	20.5%	13.1%
HE4 + CA72.4	48.4%	37.9%	29.8%
HE4 + SMRP	48.3%	38.0%	29.2%
CA125 + HE4 + CA72.4	51.7%	40.7%	34.5%
CA125 + HE4 + SMRP	51.6%	41.7%	33.7%
CA125 + CA72.4 + SMRP	28.6%	20.1%	14.6%
HE4 + CA72.4 + SMRP	48.4%	37.9%	29.8%
CA125 + HE4 + CA72.4 + SMRP	51.7%	39.1%	34.6%